مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

668
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

Characteristics of Clinical Trials in Iran: A Sample of 5000 Trials Registered in Iranian Registry of Clinical Trials (IRCT)

Pages

  8-19

Keywords

Iranian registry of clinical trials (IRCT)Q1

Abstract

 Background and Objectives: A considerable number of Clinical trials are conducted in Iran each year. Not much is known about the characteristics of them, this study aimed to investigate key characteristics of Iranian Clinical trials. Methods: All Clinical trial protocols registered in IRCT until November 2013 were selected. Text mining techniques were used to extract information from data that was mostly in the textual format. Stata software (v. 11) was used for both extraction and analysis. Results: Totally 5049 trials where analyzed. Trials were in 40 different areas of medicine and their annual number was increasing. The sample size of registered trials was less than 70 in most trials and showed no significant improvement during the 5-year period (Median sample size= 64, inter quartile range (IQR) = 40-100). Phase III trials comprised 8. 4% of the trials with a median sample size of 75 (IQR= 50-120). Of all phase III trials, 69% had a target sample size of less than 100. Most trials used randomization techniques (87. 2%) but failed to use placebo (65. 3%) and double/triple-blinding techniques (55. 8%). The leading sponsors for 99. 9% of trials were national bodies and 92. 2% of the trials received public funds. Only 1% of the trials were exclusively sponsored by pharmaceutical companies. Conclusion: The majority of Clinical trials conducted in Iran are investigator-initiated and are funded by the public sector. The small sample size and failures in bias control observed in the majority of trials highlights the need for revising current policies of conducting trials in Iran.

Cites

References

  • No record.
  • Cite

    APA: Copy

    FAKHRI, F., EYBPOOSH, S., & SOLAYMANI DODARAN, M.. (2019). Characteristics of Clinical Trials in Iran: A Sample of 5000 Trials Registered in Iranian Registry of Clinical Trials (IRCT). IRANIAN JOURNAL OF EPIDEMIOLOGY, 15(1 ), 8-19. SID. https://sid.ir/paper/381841/en

    Vancouver: Copy

    FAKHRI F., EYBPOOSH S., SOLAYMANI DODARAN M.. Characteristics of Clinical Trials in Iran: A Sample of 5000 Trials Registered in Iranian Registry of Clinical Trials (IRCT). IRANIAN JOURNAL OF EPIDEMIOLOGY[Internet]. 2019;15(1 ):8-19. Available from: https://sid.ir/paper/381841/en

    IEEE: Copy

    F. FAKHRI, S. EYBPOOSH, and M. SOLAYMANI DODARAN, “Characteristics of Clinical Trials in Iran: A Sample of 5000 Trials Registered in Iranian Registry of Clinical Trials (IRCT),” IRANIAN JOURNAL OF EPIDEMIOLOGY, vol. 15, no. 1 , pp. 8–19, 2019, [Online]. Available: https://sid.ir/paper/381841/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button